Pitavastatin versus pravastatin in adults with HIV-1 infection and dyslipidaemia (INTREPID): 12 week and 52 week results of a phase 4, multicentre, randomised, double-blind, superi... von Aberg, Judith A, Prof, Sponseller, Craig A, MD, Ward, Douglas J, MD, Kryzhanovski, Vladimir A, MD, Campbell, Stuart E, BBA, Thompson, Melanie A, MD

Volltext

Comparison of the Lipid-Lowering Effects of Pitavastatin 4 mg Versus Pravastatin 40 mg in Adults With Primary Hyperlipidemia or Mixed (Combined) Dyslipidemia: A Phase IV, Prospecti... von Sponseller, Craig A., MD, Morgan, Roger E., MD, Kryzhanovski, Vladimir A., MD, PhD, Campbell, Stuart E., BBA, Davidson, Michael H., MD

Volltext

Pitavastatin 4 mg Superior to Pravastatin 40 mg on LDL-C Reduction in HIV-Positive Patients with Dyslipidemia with and without Ritonavir-based Therapy von Sponseller, Craig A., MD, Campbell, Stuart E., BBA, Kryzhanovski, Vladimir A., MD, PhD, Aberg, Judith A., MD

Volltext

After 52 Weeks, Pitavastatin Superior to Pravastatin on LDL-C Lowering in Patients with HIV von Sponseller, Craig A., MD, Morgan, Roger E., MD, Kryzhanovski, Vladimir A., MD, PhD, Thompson, Melanie A., MD, Aberg, Judith A., MD

Volltext

Pitavastatin 4 mg Is Superior to Pravastatin 40 mg in LDL-C Reduction: Results from PREVAIL US Trial in Primary Hyperlipidemia or Mixed Dyslipidemia von Morgan, Roger, MD, Campbell, Stuart E., BBA, Kryzhanovski, Vladimir A., MD, Yu, Christine Y., MD, Sponseller, Craig A., MD, Davidson, Michael H., MD

Volltext

Usefulness of Preoperative Noninvasive Radionuclide Testing for Detecting Coronary Artery Disease in Candidates for Liver Transplantation von Kryzhanovski, Vladimir A., Beller, George A.

Volltext

913-121 Cardiac Risk Assessment in Liver Transplant Candidates is not Cost-effective von Kryzhanovski, Vladimir A., Beller, George A.

Volltext

PITAVASTATIN 4 MG PROVIDES SIGNIFICANTLY GREATER REDUCTION IN LDL-C COMPARED TO PRAVASTATIN 40 MG WITH NEUTRAL EFFECTS ON GLUCOSE METABOLISM: PRESPECIFIED SAFETY ANALYSIS FROM THE... von Kryzhanovski, Vladimir, Morgan, Roger, Sponseller, Craig, Davidson, Michael

Volltext

SHORT-TERM AND LONG-TERM EFFECTS OF PITAVASTATIN AND SIMVASTATIN ON FASTING PLASMA GLUCOSE IN PATIENTS WITH PRIMARY HYPERLIPIDEMIA OR MIXED DYSLIPIDEMIA AND ≥2 RISK FACTORS FOR... von Kryzhanovski, Vladimir, Eriksson, Mats, Hounslow, Neil, Sponseller, Craig

Volltext

SHORT-TERM AND LONG-TERM EFFECTS OF PITAVASTATIN AND SIMVASTATIN ON FASTING PLASMA GLUCOSE IN PATIENTS WITH PRIMARY HYPERLIPIDEMIA OR MIXED DYSLIPIDEMIA AND ≥2 RISK FACTORS FOR COR... von Kryzhanovski, Vladimir, Eriksson, Mats, Hounslow, Neil, Sponseller, Craig

Volltext

ATORVASTATIN BUT NOT PITAVASTATIN SIGNIFICANTLY INCREASES FASTING PLASMA GLUCOSE IN PATIENTS WITH TYPE 2 DIABETES AND COMBINED DYSLIPIDEMIA von Kryzhanovski, Vladimir, Gumprecht, Janusz, Zhu, Baojin, Yu, Christine Y, Hounslow, Neil, Sponseller, Craig A

Volltext

Pitavastatin 4 mg Provides Superior LDL-C Reduction vs. Pravastatin 40 mg Over 12 weeks in HIV-Infected Adults with Dyslipidemia, the INTREPID Trial von Sponseller, Craig A., MD, Morgan, Roger, MD, Campbell, Stuart, BBA, Kryzhanovski, Vladimir, MD, Kartman, Cynthia, RN, BSN, Aberg, Judith, MD, Thompson, Melanie, MD

Volltext